David A. Liebner

Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

Margaret von Mehren, John M. Kane, Mark Agulnik et al. · Journal of the National Comprehensive Cancer Network · 2022 · 1.2K citations · Full text

Medicine, Oncology, Surgery +17

NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021

Margaret von Mehren, John M. Kane, Marilyn M. Bui et al. · Journal of the National Comprehensive Cancer Network · 2020 · 303 citations

Medicine, Oncology, Radiation Oncology +16

Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial

Sandra P. D’Angelo, Dejka M. Araujo, Albiruni R. Abdul Razak et al. · The Lancet · 2024 · 263 citations · Full text

Medicine, Oncology, Chemotherapy +13

Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial

David S. Hong, Brian A. Van Tine, Swethajit Biswas et al. · Nature Medicine · 2023 · 194 citations · Full text

Medicine, Immunology, Oncology +17

NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022

Margaret von Mehren, John M. Kane, Richard F. Riedel et al. · Journal of the National Comprehensive Cancer Network · 2022 · 129 citations · Full text

Medicine, Molecular Medicine, Oncology +16